摘要
目的:探讨不同给药方案治疗幽门螺杆菌(Hp)感染的经济学效果。方法:102例Hp感染的消化性溃疡患者随机分为3组,给予奥美拉唑+阿莫西林+胶体果胶铋(A组)、雷贝拉唑+阿莫西林+胶体果胶铋(B组)、泮托拉唑+阿莫西林+胶体果胶铋(C组),采用成本-效果分析法进行评价。结果:A、B、C组的Hp清除率及溃疡愈合率的成本-效果比分别为1027.31、976.79、967.40及921.05、915.77、936.16。结论:B组方案较佳。
OBJECTIVE： To evaluate the economic .effectiveness of different pharmacotherapentic schemes of Prazoles for helicobacteria pylori （Hp） infection. METHODS： 102 patietns with peptic ulcer were randomly assigned to receive Omeprazole ＋ amoxicillin ＋ Colloidal bismmth pectin （Group A）, Rabeprazole ＋ Amoxicillin ＋ Colloidal bismmth pectin （Group B） or Rebeprazole ＋ amoxicillin ＋ Colloidal bismmth pectin （Group C） . The cost- effectiveness analysis was conducted on the three schemes. RESULTS： The cost - effectiveness ratios of groups A, B and C on Hp clearance rates were 1 027.31, 976.79 and 967.40, respectively, and on peptic ulcer healing rates were 921.05, 915.77 and 936.16, respectively. CONCLUSION： Scheme B is the best one for Hp infection.
出处
《中国药房》
CAS
CSCD
北大核心
2008年第17期1289-1291,共3页
China Pharmacy
